Status:
COMPLETED
Genetics of Familial and Sporadic ALS
Lead Sponsor:
Northwestern University
Conditions:
Amyotrophic Lateral Sclerosis (ALS)
Familial Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
We are collecting blood samples, clinical and family information from ALS (amyotrophic lateral sclerosis) patients and their families to identify causes of ALS and ALS/dementia.
Detailed Description
The investigators' long term goals are to improve diagnosis and develop effective treatments that arrest or ameliorate symptoms of ALS, and possibly delay or prevent disease onset in individuals at ri...
Eligibility Criteria
Inclusion
- Patients with Amyotrophic Lateral Sclerosis or ALS and frontotemporal dementia
- Selected family members, generally brothers and sisters of an ALS patient, the patient's parents
Exclusion
- Under 18 years old
Key Trial Info
Start Date :
January 1 1991
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2023
Estimated Enrollment :
13521 Patients enrolled
Trial Details
Trial ID
NCT00821132
Start Date
January 1 1991
End Date
January 1 2023
Last Update
January 26 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States, 60611